0000950170-24-037389.txt : 20240327
0000950170-24-037389.hdr.sgml : 20240327
20240327173617
ACCESSION NUMBER: 0000950170-24-037389
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240325
FILED AS OF DATE: 20240327
DATE AS OF CHANGE: 20240327
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Violette Shelia M.
CENTRAL INDEX KEY: 0002016144
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38433
FILM NUMBER: 24792294
MAIL ADDRESS:
STREET 1: Q32 BIO INC.
STREET 2: 830 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Q32 Bio Inc.
CENTRAL INDEX KEY: 0001661998
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 473468154
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 830 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 781-999-0232
MAIL ADDRESS:
STREET 1: 830 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
FORMER COMPANY:
FORMER CONFORMED NAME: Homology Medicines, Inc.
DATE OF NAME CHANGE: 20151228
4
1
ownership.xml
4
X0508
4
2024-03-25
0001661998
Q32 Bio Inc.
QTTB
0002016144
Violette Shelia M.
Q32 BIO INC.
830 WINTER STREET
WALTHAM
MA
02451
false
true
false
false
Chief Scientific Officer
false
Stock Option (Right to Buy)
16.82
2024-03-25
4
A
false
56413
0.00
A
2034-03-24
Common Stock
56413
56413
D
25% of the shares underlying this option shall vest and become exercisable on March 25, 2025, with the remainder vesting in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.
/s/ Eric Bell, Attorney-in-Fact
2024-03-27